A case of anaphylaxis to Pollinex® Quattro MPL-4

We described the first case reported in literature of anaphylactic shock after administration of pollen extract vaccine chemically modified (allergoid) adsorbed onto L-Tyrosine depot adjuvanted with monophosphoryl lipid A (Pollinex® Quattro MPL-4).

Saved in:
Bibliographic Details
Published inEuropean annals of allergy and clinical immunology Vol. 46; no. 1; pp. 46 - 48
Main Authors BORGONOVO, L, PICONI, S, FUSI, A, IEMOLI, E
Format Journal Article
LanguageEnglish
Published Fidenza Mattioli 1885 2014
Subjects
Anaphylaxis - chemically induced
Biological and medical sciences
Humans
Immunopathology
Lipid A - adverse effects
Lipid A - analogs & derivatives
Male
Medical sciences
Middle Aged
Vaccines - adverse effects
Immunopathology
Allergy
Allergoid
Desensitization
Subcutaneous
Lipids
monophosphoryl lipid A
Growth factor receptor
Anaphylaxis
Immunology
Treatment
subcutaneous allergen immunotherapy (SCIT)
C-Onc gene
Immunotherapy
Protooncogene
allergoid
Online AccessGet full text

Cover

More Information
Summary:We described the first case reported in literature of anaphylactic shock after administration of pollen extract vaccine chemically modified (allergoid) adsorbed onto L-Tyrosine depot adjuvanted with monophosphoryl lipid A (Pollinex® Quattro MPL-4).
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1764-1489